Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612687 · ClinicalTrials.gov registry record
Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT03612687: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03612687 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03612687 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a pilot study with the primary objective to validate the use of advanced minimally invasive hemodynamic monitoring with the PreSep™ Central Venous Oximetry Catheter, the Vigileo™ monitor, and FloTrac™ sensor for perioperative fluid management in Hepatobiliary and Pancreas Surgery. All of these devices and monitors are FDA approved devices and routinely used in the perioperative setting for these cases.
Primary Outcome
Cardiocirculatory, respiratory, neurological, renal, infectious and major bleeding events
Interventions
- DEVICE Minimally invasive hemodynamic monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-11 |
What the finished NCT03612687 record still lists
NCT03612687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Minimally invasive hemodynamic monitoring is the first listed.
NCT03612687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03612687 about?
NCT03612687 is a clinical study titled "Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery". This is a pilot study with the primary objective to validate the use of advanced minimally invasive hemodynamic monitoring with the PreSep™ Central Venous Oximetry Catheter, the Vigileo™ monitor, and FloTrac™ sensor for perioperative fluid management in Hepatobiliary and Pancreas Surgery. All of the...
What is the current status of trial NCT03612687?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2014-11.
What interventions are being tested in trial NCT03612687?
The interventions under investigation include: Minimally invasive hemodynamic monitoring (DEVICE).
Who is sponsoring clinical trial NCT03612687?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia